Syncona Portfolio Holdings LP has filed a 13F Notice with the SEC, detailing changes in its investment portfolio as of September 30, 2026. This filing is significant as it provides insights into the company’s investment strategies and positions within the market.

Syncona Portfolio Holdings LP is an investment firm based in St. Peter Port, Guernsey. The company operates under the Central Index Key (CIK) 0002134096. It focuses on managing investments in the life sciences sector, particularly in biotechnology and healthcare. Recent filings include a 13F Notice on November 5, 2026, and previous filings on August 7 and May 14, 2026.

The filing indicates that Syncona Portfolio Limited, a wholly owned subsidiary of Syncona Portfolio Holdings LP, directly owns the securities reported. The investment decisions are guided by Christopher Hollowood and Kenneth Galbraith, who are part of the investment committee at Syncona Investment Management Limited. The filing states, "The securities are owned directly by Syncona Portfolio Limited and indirectly by Syncona Portfolio Holdings LP, Syncona Holdings Limited, Syncona Limited, Christopher Hollowood and Kenneth Galbraith." This highlights the interconnected nature of the entities involved in the management of the portfolio.

This filing may affect other entities in the biotech and healthcare sectors as they analyze Syncona's investment strategies. The competitive landscape could shift as firms respond to the changes made by Syncona Portfolio Holdings LP.

The filing does not say what happens next, leaving stakeholders to await further updates or additional filings that may provide more context on future actions.